Cargando…
Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
Chronic breathlessness, a persistent and disabling symptom despite optimal treatment of underlying causes, is a frightening symptom with serious and widespread impact on patients and their carers. Clinical guidelines support the use of morphine for the relief of chronic breathlessness in common long...
Autores principales: | Date, Kathryn, Williams, Bronwen, Cohen, Judith, Chaudhuri, Nazia, Bajwah, Sabrina, Pearson, Mark, Higginson, Irene, Norrie, John, Keerie, Catriona, Tuck, Sharon, Hall, Peter, Currow, David, Fallon, Marie, Johnson, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423982/ https://www.ncbi.nlm.nih.gov/pubmed/37583966 http://dx.doi.org/10.1183/23120541.00167-2023 |
Ejemplares similares
-
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo‐controlled trial
por: Johnson, Miriam J., et al.
Publicado: (2019) -
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
por: Currow, David, et al.
Publicado: (2017) -
Dr. Elizabeth Mabel Henderson
Publicado: (1911) -
P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease
por: Altree, T, et al.
Publicado: (2022) -
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)
por: Higginson, Irene J, et al.
Publicado: (2020)